Garcia Marino Insider Profile
4 Followers
Garcia Marino, Director at AgomAb Therapeutics NV ADR, holds ― shares in AgomAb Therapeutics NV ADR (Ticker: AGMB), holds ― shares in Synergy Pharmaceuticals Inc (Ticker: SGYPQ), holds 65.29K shares in Dianthus Therapeutics (Ticker: DNTH). Most recently, Garcia Marino ― shares of AgomAb Therapeutics NV ADR on ― for an estimated value of ―.
Garcia Marino has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Garcia Marino holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Garcia Marino
Garcia Marino's Trading History
AgomAb Therapeutics NV ADR
―
Director
―
―
Synergy Pharmaceuticals Inc
―
―
―
―
Dianthus Therapeutics
Aug 07, 2026
CEO & President, Director
Uninformative Buy
1.40M
$5.54M
List of latest transactions for each holding click on a transaction to see Garcia Marino's performance on stock
You May Also Like
Garcia Marino insider profile FAQ
What is the percentage of profitable transactions made by Garcia Marino?
The percentage of profitable transactions made by Garcia Marino is ―.
What is the average return per transaction made by Garcia Marino?
The average return per transaction made by Garcia Marino is ―.
What stocks does Garcia Marino hold?
Garcia Marino holds: AGMB, SGYPQ, DNTH stocks.
What was Garcia Marino’s latest transaction?
Garcia Marino latest transaction was an Uninformative Buy of ―.
What was Garcia Marino's most profitable transaction?
Garcia Marino’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Garcia Marino's role in AgomAb Therapeutics NV ADR?
Garcia Marino's role in AgomAb Therapeutics NV ADR is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.